In recent years, the panorama of pharmaceutical accessibility has undergone important modifications, significantly concerning cognitive enhancers like modafinil. This medication, originally developed to treat narcolepsy and other sleep disorders, has garnered consideration for its off-label use as a cognitive enhancer. …
